Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea · Delayed Price · Currency is KRW 421,500
+24,000 (6.04%)
Jul 1, 2026, 3:19 PM KST
Hanmi Pharm. Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Hanmi Pharm. stock has a consensus rating of "Buy" and an average price target of ₩624,615. The average 1-year stock price forecast is 48.19% higher than the current stock price, while the lowest is ₩510,000 (+21.00%) and the highest is ₩740,000 (+75.56%).
Price Target: ₩624,615 (+48.19%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Hanmi Pharm. stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 7 | 6 | 5 |
| Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 16 | 16 | 15 | 15 | 14 |
Financial Forecast
Revenue This Year
1.66T
from 1.55T
Increased by 7.43%
Revenue Next Year
1.76T
from 1.66T
Increased by 5.98%
EPS This Year
14.86K
from 13.36K
Increased by 11.19%
EPS Next Year
16.61K
from 14.86K
Increased by 11.80%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.8T | ||
| Avg | 1.7T | ||
| Low | 1.6T |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.9% | ||
| Avg | 7.4% | ||
| Low | 3.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 18,819.00 | ||
| Avg | 14,857.36 | ||
| Low | 12,729.00 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 40.8% | ||
| Avg | 11.2% | ||
| Low | -4.7% |